Targeting Lysosomal pH Restores Mitochondrial Quality Control in GBA1-Mutant Parkinsons Disease
This study demonstrates that GBA1 mutations in Parkinson's disease impair lysosomal acidification via mTORC1-driven disruption of V-ATPase assembly, leading to defective mitophagy and mitochondrial dysfunction, which can be therapeutically rescued by restoring lysosomal pH using rapamycin or acidic nanoparticles.